# FDA recall D-0407-2019

> **Hiers Enterprises, LLC dba Northwest Compounding Pharmacy** · Class II · drug recall initiated 2019-01-02.

## Product

Glutathione liquid, 200mg/ml, Rx

## Reason for recall

Lack of sterility assurance.

## Distribution

Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.

## Key facts

- **Recall number:** D-0407-2019
- **Recalling firm:** Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-01-02
- **Report date:** 2019-01-09
- **Termination date:** 2023-03-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Roseburg, OR, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0407-2019

## Citation

> AI Analytics. FDA recall D-0407-2019. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0407-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
